eNeurologicalSci (Mar 2019)

The novel de novo mutation of KIF1A gene as the cause for Spastic paraplegia 30 in a Japanese case

  • Keisuke Yoshikawa,
  • Motoi Kuwahara,
  • Kazumasa Saigoh,
  • Hiroyuki Ishiura,
  • Yuko Yamagishi,
  • Yuta Hamano,
  • Makoto Samukawa,
  • Hidekazu Suzuki,
  • Makito Hirano,
  • Yoshiyuki Mitsui,
  • Shoji Tsuji,
  • Susumu Kusunoki

Journal volume & issue
Vol. 14
pp. 34 – 37

Abstract

Read online

Spastic paraplegia 30 is a recently established autosomal recessive disease characterized by a complex form of spastic paraplegia associated with neuropathy. Homozygous mutations of KIF1A reportedly lead to hereditary spastic paraplegia or hereditary sensory and autonomic neuropathy type 2 (HSAN2), whereas heterozygous mutations can cause nonsyndromic and syndromic intellectual disability (MRD9). Here we report the case of a 37-year-old female who presented with gait disturbance complicated with moyamoya disease. Results: The patient exhibited hypotonia during infancy, after which intellectual disability, epileptic fits, spastic paraplegia, and cerebellar atrophy occurred. Genetic analysis revealed a novel de novo mutation (c.254C > A, p.A85D) in the motor domain of KIF1A. Keywords: KIF1A, Spastic paraplegia 30: SPG30, Moyamoya disease, Gene, HSAN2, Mental retardation, Autosomal dominant 9, MRD9